GSK and IQVIA Launch “Vaccine Track”

August 8, 2022

AVAC member GSK, in partnership with IQVIA, launched a new data trend platform to help improve adult vaccination in communities nationwide.

This is a first-of-its-kind platform provides publicly-accessible, quarterly data trends on adult vaccination to strengthen data transparency and empower the public health community with actionable information.

 The Vaccine Track platform enables users to: 

  • Identify vaccination trends for adults 19+ in the US across multiple vaccines 
  • Scan immunization claims data nationally and sub-nationally across years 
  • Track trends based on 2019 pre-COVID-19 baseline vaccination uptake 
  • Highlight where differences exist based on demographics (e.g., age, race/ethnicity, gender, payer type) 

Access Vaccine Track here.